Related Experiment Videos
Development and validation of a risk models for gout in patients with diabetic kidney disease
Ningyu Cai1, Mengdie Chen2, Yiyun Wang3
1Department of Orthopedics, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, 318000, China.
Insights
This study developed a nomogram to predict gout risk in patients with diabetic kidney disease (DKD). The tool helps clinicians identify high-risk individuals for early intervention.
Area of Science:
- Nephrology and Endocrinology
- Metabolic Diseases
- Rheumatology
Background:
- Diabetic kidney disease (DKD) significantly increases the risk of developing gout.
- The co-occurrence of DKD and gout negatively impacts patient health.
- Accurate gout risk assessment is crucial for DKD patients.
Purpose of the Study:
- To identify risk factors for gout in patients with DKD.
- To develop and validate a clinical nomogram for estimating individual gout risk in DKD patients.
Main Methods:
- Retrospective analysis of 5,670 DKD patients from two centers.
- Utilized Best Subset Regression, LASSO, and multivariate logistic regression for risk factor selection.
- Generated and validated a nomogram using AUC, calibration plots, and decision curve analysis.
Main Results:
- Identified sex, BMI, fasting C-peptide, eGFR, and serum urate as key risk factors.
- The nomogram demonstrated strong predictive performance with AUCs ranging from 0.770 to 0.784 across cohorts.
- Calibration plots confirmed good agreement between predicted and observed gout risk.
Conclusions:
- A validated prognostic nomogram can accurately estimate gout risk in DKD patients.
- This tool aids clinicians in identifying high-risk individuals.
- Facilitates early and targeted preventive strategies for gout in the DKD population.
Background:
Patients with diabetic kidney disease (DKD) exhibit a markedly elevated risk of developing gout. The coexistence of these conditions severely compromises health. Consequently, risk for gout necessitates evaluation within this patient cohort. This study aimed to identify risk factoes of gout among DKD patients and to establish and validate a clinically usable nomogram for estimating individual gout risk.
Methods:
A two-center, retrospective analysis enrolling DKD patients managed at the Metabolic Management Centers of Taizhou Central Hospital and Yuhuan Second People's Hospital between September 2017 and February 2025 was conducted. Key risk factors were selected using an integrated approach combining Best Subset Regression and Least Absolute Shrinkage and Selection Operator analysis, followed by multivariate logistic regression to identify independent correlates of gout. A risk nomogram was then generated. Model performance was assessed using Area Under the Receiver Operating Characteristic Curve (AUC) values, calibration plots, Hosmer-Lemeshow goodness-of-fit tests, and a decision curve analysis (DCA) approach.
Results:
Overall, 5,670 DKD patients were analyzed. Of these, 4,617 participants from Yuhuan Second People's Hospital were divided into training and internal validation cohorts, while 1,088 patients from Taizhou Central Hospital formed an external validation cohort. Variables incorporated into the final model included sex, body mass index, fasting C-peptide, estimated glomerular filtration rate, and serum urate. The nomogram displayed strong discrimination with respective AUCs of 0.784, 0.782, and 0.770 in the training, internal validation, and external validation cohorts. Calibration plots showed close alignment between predicted and observed outcomes (Hosmer-Lemeshow p-values 0.769, 0.332, and 0.520 for the respective cohorts). DCA demonstrated net benefits across various threshold probabilities deemed clinically useful.
Conclusions:
The prognostic nomogram developed in validated in this study has been specifically tailored to estimate gout risk in DKD. The tool can help clinicians identify high-risk individuals and implement early, targeted preventive strategies.
Clinical Trial Number:
Not applicable.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Diabetic Nephropathy
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention